| pubmed-article:17551661 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17551661 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
| pubmed-article:17551661 | lifeskim:mentions | umls-concept:C0073992 | lld:lifeskim |
| pubmed-article:17551661 | lifeskim:mentions | umls-concept:C0117996 | lld:lifeskim |
| pubmed-article:17551661 | lifeskim:mentions | umls-concept:C2349179 | lld:lifeskim |
| pubmed-article:17551661 | lifeskim:mentions | umls-concept:C0439810 | lld:lifeskim |
| pubmed-article:17551661 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:17551661 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:17551661 | pubmed:dateCreated | 2007-6-6 | lld:pubmed |
| pubmed-article:17551661 | pubmed:abstractText | To investigate the magnitude of change in morning peak expiratory flow (PEF), asthma symptoms, and rescue beta2-agonist use, when the aim of treatment is to achieve guideline-defined control. | lld:pubmed |
| pubmed-article:17551661 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17551661 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17551661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17551661 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17551661 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:17551661 | pubmed:issn | 1471-4418 | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:BousquetJeanJ | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:BatemanEric... | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:BoonsawatWatc... | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:BagdonasAlfre... | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:WoodcockAshle... | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:GibbsMichael... | lld:pubmed |
| pubmed-article:17551661 | pubmed:author | pubmed-author:GOAL... | lld:pubmed |
| pubmed-article:17551661 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17551661 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:17551661 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17551661 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17551661 | pubmed:pagination | 155-61 | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:meshHeading | pubmed-meshheading:17551661... | lld:pubmed |
| pubmed-article:17551661 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17551661 | pubmed:articleTitle | Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. | lld:pubmed |
| pubmed-article:17551661 | pubmed:affiliation | North West Lung Centre, Wythenshawe Hospital, Manchester, UK. ashley.woodcock@manchester.ac.uk | lld:pubmed |
| pubmed-article:17551661 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17551661 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:17551661 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17551661 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
